Sentinel node biopsy alone versus completion axillary node dissection in node positive breast cancer: Systematic review and meta-analysis

International Journal of Breast Cancer

Volumn 2014, Issue , 2014, Pages

  Ram, Rachna ^a   Singh, Jasprit ^b   McCaig, Eddie ^c  

^a Hutt Valley District Health Board   (New Zealand)

^b FIJI NATIONAL UNIVERSITY   (Fiji)

^c Ministry of Health   (Fiji)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; HUMAN; LYMPH NODE DISSECTION; META ANALYSIS; OVERALL SURVIVAL; RETROSPECTIVE STUDY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SYSTEMATIC REVIEW;

EID: 84931006916     PISSN: 20903170     EISSN: 20903189     Source Type: Journal    
DOI: 10.1155/2014/513780     Document Type: Review

References (30)

1. Halsted W. S., I. The results of operations for the cure of cancer of the breast performed at the johns hopkins hospital from June, 1889, to January, 1894. Annals of Surgery 1894 20 5 497 555
2. Patey D. H., Dyson W. H., The prognosis of carcinoma of the breast in relation to the type of operation performed. British Journal of Cancer 1948 2 7 13 10.1038/bjc.1948.2
3. Fisher B., Redmond C., Fisher E. R., Bauer M., Wolmark N., Wickerham D. L., Deutsch M., Montague E., Margolese R., Foster R., Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. The New England Journal of Medicine 1985 312 11 674 681 10.1056/NEJM198503143121102 2-s2.0-0021956483
4. Fisher B., Jeong J.-H., Anderson S., Bryant J., Fisher E. R., Wolmark N., Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. The New England Journal of Medicine 2002 347 8 567 575 10.1056/NEJMoa020128 2-s2.0-0037158614
5. Fisher B., Bauer M., Margolese R., Poisson R., Pilch Y., Redmond C., Wolmark N., Deutsch M., Montague E., Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. The New England Journal of Medicine 1985 312 11 665 673 10.1056/NEJM198503143121101 2-s2.0-0021923669
6. Fisher B., Laboratory and clinical research in breast cancer-a personal adventure: the David A. Karnofsky Memorial Lecture. Cancer Research 1980 40 11 3863 3874 2-s2.0-0019198579
7. Gould E. A., Winship T., Philbin P. H., Kerr H. H., Observations on a "sentinel node" in cancer of the parotid. Cancer 1960 13 77 78
8. Tanis P. J., Nieweg O. E., Olmos R. A. V., Rutgers E. J. T., Kroon B. B. R., History of sentinel node and validation of the technique. Breast Cancer Research 2001 3 2 109 112 10.1186/bcr281 2-s2.0-0035063136
9. Krag D. N., Anderson S. J., Julian T. B., Brown A. M., Harlow S. P., Costantino J. P., Ashikaga T., Weaver D. L., Mamounas E. P., Jalovec L. M., Frazier T. G., Noyes R. D., Robidoux A., Scarth H. M., Wolmark N., Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. The Lancet Oncology 2010 11 10 927 933 10.1016/S1470-2045(10)70207-2 2-s2.0-77957358827
10. Maaskant-Braat A. J., Voogd A. C., van de Poll-Franse L. V., Coebergh J. W. W., Nieuwenhuijzen G. A., Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node. Breast 2012 21 4 524 528 10.1016/j.breast.2012.03.008 2-s2.0-84863875749
11. Straver M. E., Meijnen P., Van Tienhoven G., Van De Velde C. J. H., Mansel R. E., Bogaerts J., Demonty G., Duez N., Cataliotti L., Klinkenbijl J., Westenberg H. A., Van Der Mijle H., Hurkmans C., Rutgers E. J. T., Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. Journal of Clinical Oncology 2010 28 5 731 737 10.1200/JCO.2008.21.7554 2-s2.0-77649225343
12. Giuliano A. E., Hunt K. K., Ballman K. V., Beitsch P. D., Whitworth P. W., Blumencranz P. W., Leitch A. M., Saha S., McCall L. M., Morrow M., Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. Journal of the American Medical Association 2011 305 6 569 575 10.1001/jama.2011.90 2-s2.0-79751522951
13. Moher D., Liberati A., Tetzlaff J., Altman D. G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009 339 7716 332 336 10.1136/bmj.b2535 2-s2.0-69449100622
14. Schulz K. F., Altman D. G., Moher D., CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Annals of Internal Medicine 2010 152 11 726 732 10.7326/0003-4819-152-11-201006010-00232 2-s2.0-77953395873
15. Solá M., Alberro J. A., Fraile M., Santesteban P., Ramos M., Fabregas R., Moral A., Ballester B., Vidal S., Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000. Annals of Surgical Oncology 2013 20 1 120 127 10.1245/s10434-012-2569-y 2-s2.0-84871785984
16. Tierney J. F., Stewart L. A., Ghersi D., Burdett S., Sydes M. R., Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007 8, article 16 10.1186/1745-6215-8-16 2-s2.0-34547450763
17. Galimberti V., Cole B. F., Zurrida S., Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. The Lancet Oncology 2013 14 4 297 305 10.1016/S1470-2045(13)70035-4 2-s2.0-84875804030
18. Bilimoria K. Y., Bentrem D. J., Hansen N. M., Bethke K. P., Rademaker A. W., Ko C. Y., Winchester D. P., Winchester D. J., Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. Journal of Clinical Oncology 2009 27 18 2946 2953 10.1200/JCO.2008.19.5750 2-s2.0-67649921350
19. Yi M., Giordano S. H., Meric-Bernstam F., Mittendorf E. A., Kuerer H. M., Hwang R. F., Bedrosian I., Rourke L., Hunt K. K., Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: Experience from the SEER database. Annals of Surgical Oncology 2010 17 343 351 10.1245/s10434-010-1253-3 2-s2.0-78149265757
20. Galimberti V., Botteri E., Chifu C., Gentilini O., Luini A., Intra M., Baratella P., Sargenti M., Zurrida S., Veronesi P., Rotmensz N., Viale G., Sonzogni A., Colleoni M., Veronesi U., Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Research and Treatment 2012 131 3 819 825 10.1007/s10549-011-1486-2 2-s2.0-84856224710
21. Guenther J. M., Hansen N. M., DiFronzo L. A., Giuliano A. E., Collins J. C., Grube B. L., O'Connell T. X., Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Archives of Surgery 2003 138 1 52 56 10.1001/archsurg.138.1.52 2-s2.0-0037223824
22. Spiguel L., Yao K., Winchester D. J., Gorchow A., Du H., Sener S. F., Martz B., Turk M., Barrera E., Winchester D. P., Sentinel node biopsy alone for node-positive breast cancer: 12-year experience at a single institution. Journal of the American College of Surgeons 2011 213 1 122 128 10.1016/j.jamcollsurg.2011.03.034 2-s2.0-79959504331
23. The Cochrane Collaboration, Review Manager (Revman) 2012 Copenhagen, Denmark Centre TNC
24. Fletcher J., What is heterogeneity and is it important? British Medical Journal 2007 334 7584 94 96 10.1136/bmj.39057.406644.68 2-s2.0-33846279812
25. Glechner A., Wockel A., Gartlehner G., Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: a systematic review and meta-analysis. European Journal of Cancer 2013 49 4 812 825 10.1016/j.ejca.2012.09.010
26. Francissen C. M. T. P., Dings P. J. M., van Dalen T., Strobbe L. J. A., van Laarhoven H. W. M., de Wilt J. H. W., Axillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literature. Annals of Surgical Oncology 2012 19 13 4140 4149 10.1245/s10434-012-2490-4 2-s2.0-84876458588
27. Fisher B., Anderson S. J., The breast cancer alternative hypothesis: is there evidence to justify replacing it? Journal of Clinical Oncology 2010 28 3 366 374 10.1200/JCO.2009.26.8292 2-s2.0-75749140165
28. Morrow M., Patterns of care with a positive sentinel node: echoes of an opportunity missed. Annals of Surgical Oncology 2009 16 9 2429 2430 10.1245/s10434-009-0552-z 2-s2.0-68949219431
29. Latosinsky S., Berrang T. S., Cutter C. S., George R., Olivotto I., Julian T. B., Hayashi A., Baliski C., Croshaw R. L., Erb K. M., Chen J., Baxter N. N., Brasel K. J., Brown C. J., Chaudhury P., Divino C. M., Dixon E., Dubois L., Fitzgerald G. W. N., Henteleff H. J. A., Kirkpatrick A. W., MacLean A. R., Mastracci T. M., McLeod R. S., Morris A. M., Neumayer L. A., Temple L. K., McKenzie M. E., Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis. Canadian Journal of Surgery 2012 55 1 66 69 10.1503/cjs.036011 2-s2.0-84863371701
30. Benson J. R., Management of breast-cancer patients with sentinel-node micrometastases. The Lancet Oncology 2013 14 4 266 267 10.1016/S1470-2045(13)70074-3 2-s2.0-84875811165